Biofilm formation and serum susceptibility in Pseudomonas aeruginosa
- 360 Downloads
Pseudomonas aeruginosa (P. aeruginosa) is one of the most important opportunistic pathogens. The pathogenicity of P. aeruginosa has been associated with multiple bacterial virulence factors. The aim of this study was to evaluate the association between P. aeruginosa strains obtained from various clinical samples and resistance to antibiotics and pathogenicity factors, such as resistance to serum bactericidal activity and biofilm formation. This study included 121 P. aeruginosa strains isolated from clinical samples; 65 of the isolated P. aeruginosa strains were carbapenem-resistant, and 56 were carbapenem-sensitive. Carbapenem-resistant P. aeruginosa strains were more often resistant to the majority of tested antibiotics, compared to carbapenem-sensitive strains. We did not find any statistically significant difference between resistance to carbapenems and serum resistance and ability of tested P. aeruginosa strains to produce biofilms. Carbapenem-resistant P. aeruginosa strains were recovered from the urinary tract significantly more often (75.0%) than carbapenem-sensitive P. aeruginosa strains (25.0%). Carbapenem-sensitive P. aeruginosa strains were recovered significantly more often from the respiratory tract than carbapenem-resistant strains, 60.0% and 40.0%, respectively. All the P. aeruginosa strains recovered from blood were serum-resistant. P. aeruginosa strains recovered from the respiratory tract and wounds were significantly frequently serum sensitive, 95.6% and 56.6%, respectively. We did not find any differences in biofilm production among the P. aeruginosa strains recovered from different sources.
KeywordsP. aeruginosa Antibiotic susceptibility Biofilm Carbapenem-resistance Serum-bactericidal activity
Unable to display preview. Download preview PDF.
- Hoban D.J., Biedenbach D.J., Mutnick A.H., Jones R.N., Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn.Microbiol.Infect.Dis, 2003, 45, 279–285PubMedCrossRefGoogle Scholar
- Hancock R.E., Mutharia L.M., Chan L., Darveau R.P., Speert D.P., Pier G.B., Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect.Immun, 1983, 42, 170–177PubMedCentralPubMedGoogle Scholar
- Crespo M.P., Woodford N., Sinclair A., Kaufmann M.E., Turton J., Glover J., Velez J.D., Castaneda C.R., Recalde M., Livermore D.M., Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallobeta-lactamase, in a tertiary care center in Cali, Colombia. J.Clin.Microbiol, 2004, 42, 5094–5101PubMedCentralPubMedCrossRefGoogle Scholar
- Tam V.H., Chang K.T., Abdelraouf K., Brioso C.G., Ameka M., McCaskey L.A., Weston J.S., Caeiro J.P., Garey K.W., Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob.Agents Chemother, 2010, 54, 1160–1164PubMedCentralPubMedCrossRefGoogle Scholar
- Hocquet D., Berthelot P., Roussel-Delvallez M., Favre R., Jeannot K., Bajolet O., Marty N., Grattard F., Mariani-Kurkdjian P., Bingen E., Husson M.O., Couetdic G., Plesiat P., Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob.Agents Chemother, 2007, 51, 3531–3536PubMedCentralPubMedCrossRefGoogle Scholar
- European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoints tables for interpretation of MICs and zone diameters, Version 2.0. 2012Google Scholar
- Sahly H., Aucken H., Benedi V.J., Forestier C., Fussing V., Hansen D.S., Ofek I., Podschun R, Sirot D, Tomas JM, Sandvang D, and Ullmann U, Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob.Agents Chemother, 2004, 48, 3477–3482PubMedCentralPubMedCrossRefGoogle Scholar
- Lagatolla C., Tonin E.A., Monti-Bragadin C., Dolzani L., Gombac F., Bearzi C., Edalucci E., Gionechetti F., Rossolini G.M., Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-beta-lactamase determinants in European hospital. Emerg.Infect.Dis, 2004, 10, 535–538PubMedCrossRefGoogle Scholar
- Kouda S., Ohara M., Onodera M., Fujiue Y., Sasaki M., Kohara T., Kashiyama S., Hayashida S., Harino T., Tsuji T., Itaha H., Gotoh N., Matsubara A., Usui T., Sugai M., Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima. J.Antimicrob.Chemother, 2009, 64, 46–51PubMedCrossRefGoogle Scholar
- Manu D., Lupan I., Popescu O., Mechanisms of pathogenesis and antibiotics resistance in Escherichia coli. Annals of RSCB, 2011, 2, 7–19Google Scholar